Arnout, J.( J. Arnout)
patient heparin group anticoagulation level study patency placebo therapy trial thromboplastin baseline alteplase heparin group artery treatment thromboplastin times artery patency european d-dimer levels baseline value blood administration sample value fibrinogen complication table grade subgroup infarction analysis infusion aspirin thromboplastin time angiography study group d-dimer coagulation center result plasma thmmbolytic therapy treatment allocation suboptimal anticoagulation 144 h 6 days ecsg trial patency rate heparin trial placebo group patients randomized 149 patients ischemia system blood samples fibrinogen levels thrombolytic treatment heparin-treated patients suboptimal 652 patients coagulation system 281 patients fibrin patent subgroups reinfarctinn wpt ~reviewed trealment groups lheparin subgroup fibrinogen levels patent thmmbogenic stimuli placebo 01 heparin thmmbop !astm tnnes patency rates ii parlial thromhoplartin limes study group trial selection cril &ia placeb +tre patients onset ofthrombnlytic treatment timi grades 2 timi grade 2
1 Most Recent Publications
Correlation between level of heparinization and patency of the infarct-related coronary artery after treatment of acute myocardial infarction with alteplase (rt-PA)
Simoons, M.L. Rapold, H.J. Collen, D. Verstraete, M. Arnout, J.